
As shortages end, pharmacies that compound GLP-1s face lawsuits, stricter board oversight, and tougher FDA enforcement.

As shortages end, pharmacies that compound GLP-1s face lawsuits, stricter board oversight, and tougher FDA enforcement.

Pharmacists can help patients maintain muscle mass, meet their protein needs, and prevent nutritional deficiencies through evidence-based guidance that supports better overall health.

A collection of 4 major independent pharmacy groups filed an amicus brief urging Iowa representatives to shut down a recent challenge to proposed PBM legislation.

This episode explores a dynamic pharmacy profession and how self-inflection can lead to pharmacists achieving their passions and improving care in their communities.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses the emerging role of artificial intelligence in pharmacy and how it’s used alongside other developed technologies.

Balancing opioid use with compassion and clinical best practices ensures safe and patient-centered care, supporting pain management and addiction.

With uncertainty in dosing recommendations, researchers aim to assess the efficacy of pneumococcal conjugate vaccines for the pediatric population.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses why the underutilization of technology could be hurting pharmacy businesses.

Celebrate the vital role of pharmacists in health care this American Pharmacists Month.

Further, they found weight lose prior to 75-g oral glucose tolerance test was a preventative factor for both impaired glucose tolerance and diabetes.

Amgen launches AmgenNow, which is a new direct-to-patient program that will start with evolucumab.

As the sixth approval for roflumilast in less than 4 years, the cream is expected to impact the 1.8 million children who have reported atopic dermatitis.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses the opportunities incorporating pharmacy technology can create for pharmacies and their businesses.

Don Roosan, PharmD, PhD, discusses the ethical implications of AI in pharmacy, focusing on patient safety, transparency, and the importance of human connection in care.

Don Roosan, PharmD, PhD, discusses the changing technology, challenging conventional boundaries of pharmaceutical practice through telepharmacy and artificial intelligence.

Researchers conduct a pilot study that assesses clinical pharmacists’ interventions and management of chronic diseases for older adults living in senior housing facilities.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Hannah Fish, PharmD, CPHQ, about the NCPA’s maternal immunizations tool kit and pharmacist support for mothers.

Prior to the government shutdown, the FDA approved a generic version of mifeprisone without a public announcement.

As contraceptive care services remain fragmented across many US states, pharmacists are seemingly rising as key touch points for women’s health management and various types of reproductive care.

Significant patient reports show a lack of response to treatment for community-acquired pneumonia, leading researchers to investigate the use of corticosteroids.

Ashley Moose, PharmD, owner of Moose Pharmacy of Monroe and director of network development at CPESN USA, capped off this fall’s event and discussed where to access sessions on demand.

With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss their use of the PRISM platform for providing contraceptive and family-planning services.

This is the first Bruton tyrosine kinase inhibitor FDA approved for chronic spontaneous urticaria.

This month, Drug Topics® explores a new avenue of pharmacy each week, including AI technology, student education, innovative community services, and the expansion of clinical care.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Shane Desselle, RPh, PhD, FAPhA, professor of Pharmacy Practice and Social Pharmacy at Touro University California.

Amid ongoing approaches to lower drug prices for US patients, like the Most-Favored-Nation policy, this is another partnership the Trump Administration believes will improve access challenges.

In part 2 of our interview, Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss the evolution of contraceptive services and how pharmacy is supporting rural communities and their patients.

In part 3 of our interview with Bill Wolfe, COO of WriteWise, he discusses the technology backing his team’s approach to forever changing how pharmacy benefits are distributed in the US.

Since 2016, the rate of gabapentin prescribing slowed but is still increasing, especially for women and older adults.